Literature DB >> 33381076

Skeletal Muscle-Restricted Expression of Human SOD1 in Transgenic Mice Causes a Fatal ALS-Like Syndrome.

Lee J Martin1,2,3,4, Margaret Wong1.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal heterogeneous neurodegenerative disease that causes motor neuron (MN) loss and skeletal muscle paralysis. It is uncertain whether this degeneration of MNs is triggered intrinsically and is autonomous, or if the disease initiating mechanisms are extrinsic to MNs. We hypothesized that skeletal muscle is a primary site of pathogenesis in ALS that triggers MN degeneration. Some inherited forms of ALS are caused by mutations in the superoxide dismutase-1 (SOD1) gene, that encodes an antioxidant protein, so we created transgenic (tg) mice expressing wild-type-, G37R-, and G93A-human SOD1 gene variants only in skeletal muscle. Presence of human SOD1 (hSOD1) protein in skeletal muscle was verified by western blotting, enzyme activity gels, and immunofluorescence in myofibers and satellite cells. These tg mice developed limb weakness and paresis with motor deficits, limb and chest muscle wasting, diaphragm atrophy, and age-related fatal disease with a lifespan shortening of 10-16%. Brown and white adipose tissue also became wasted. Myofibers of tg mice developed crystalline-like inclusions, individualized sarcomere destruction, mitochondriopathy with vesiculation, DNA damage, and activated p53. Satellite cells became apoptotic. The diaphragm developed severe loss of neuromuscular junction presynaptic and postsynaptic integrity, including decreased innervation, loss of synaptophysin, nitration of synaptophysin, and loss of nicotinic acetylcholine receptor and scaffold protein rapsyn. Co-immunoprecipitation identified hSOD1 interaction with rapsyn. Spinal cords of tg mice developed gross atrophy. Spinal MNs formed cytoplasmic and nuclear inclusions, axonopathy, mitochondriopathy, accumulated DNA damage, activated p53 and cleaved caspase-3, and died. Tg mice had a 40-50% loss of MNs. This work shows that hSOD1 in skeletal muscle is a driver of pathogenesis in ALS, that involves myofiber and satellite cell toxicity, and apparent muscle-adipose tissue disease relationships. It also identifies a non-autonomous mechanism for MN degeneration explaining their selective vulnerability as likely a form of target-deprivation retrograde neurodegeneration.
Copyright © 2020 Martin and Wong.

Entities:  

Keywords:  DNA damage; TDP-43; aging; motor neuron; rapsyn

Year:  2020        PMID: 33381076      PMCID: PMC7767933          DOI: 10.3389/fneur.2020.592851

Source DB:  PubMed          Journal:  Front Neurol        ISSN: 1664-2295            Impact factor:   4.003


  10 in total

Review 1.  Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Sagar Verma; Shiffali Khurana; Abhishek Vats; Bandana Sahu; Nirmal Kumar Ganguly; Pradip Chakraborti; Mandaville Gourie-Devi; Vibha Taneja
Journal:  Mol Neurobiol       Date:  2022-01-08       Impact factor: 5.590

2.  KLF15 overexpression in myocytes fails to ameliorate ALS-related pathology or extend the lifespan of SOD1G93A mice.

Authors:  Ryan Massopust; Devin Juros; Dillon Shapiro; Mikayla Lopes; Saptarsi M Haldar; Thomas Taetzsch; Gregorio Valdez
Journal:  Neurobiol Dis       Date:  2021-12-11       Impact factor: 5.996

3.  Motoneuron Diseases.

Authors:  Francesco Lotti; Serge Przedborski
Journal:  Adv Neurobiol       Date:  2022

Review 4.  SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells.

Authors:  Caterina Peggion; Valeria Scalcon; Maria Lina Massimino; Kelly Nies; Raffaele Lopreiato; Maria Pia Rigobello; Alessandro Bertoli
Journal:  Antioxidants (Basel)       Date:  2022-03-23

5.  Basal forebrain magnocellular cholinergic systems are damaged in mice following neonatal hypoxia-ischemia.

Authors:  Frances J Northington; Panagiotis Kratimenos; Victoria Turnbill; Debra L Flock; Daniella Asafu-Adjaye; Raul Chavez-Valdez; Lee J Martin
Journal:  J Comp Neurol       Date:  2021-11-03       Impact factor: 3.028

6.  Alteration of the Neuromuscular Junction and Modifications of Muscle Metabolism in Response to Neuron-Restricted Expression of the CHMP2Bintron5 Mutant in a Mouse Model of ALS-FTD Syndrome.

Authors:  Robin Waegaert; Sylvie Dirrig-Grosch; Haoyi Liu; Marion Boutry; Ping Luan; Jean-Philippe Loeffler; Frédérique René
Journal:  Biomolecules       Date:  2022-03-24

Review 7.  Non-cell-autonomous pathogenic mechanisms in amyotrophic lateral sclerosis.

Authors:  Alexandra C M Van Harten; Hemali Phatnani; Serge Przedborski
Journal:  Trends Neurosci       Date:  2021-05-15       Impact factor: 13.837

8.  Chronic Intermittent Mild Whole-Body Hypothermia Is Therapeutic in a Mouse Model of ALS.

Authors:  Lee J Martin; Mark V Niedzwiecki; Margaret Wong
Journal:  Cells       Date:  2021-02-04       Impact factor: 6.600

9.  Contingent intramuscular boosting of P2XR7 axis improves motor function in transgenic ALS mice.

Authors:  Paola Fabbrizio; Jessica D'Agostino; Cassandra Margotta; Giulia Mella; Nicolò Panini; Laura Pasetto; Eliana Sammali; Flavia Raggi; Gianni Sorarù; Valentina Bonetto; Caterina Bendotti; Giovanni Nardo
Journal:  Cell Mol Life Sci       Date:  2021-12-22       Impact factor: 9.261

Review 10.  Skeletal Muscle in ALS: An Unappreciated Therapeutic Opportunity?

Authors:  Silvia Scaricamazza; Illari Salvatori; Alberto Ferri; Cristiana Valle
Journal:  Cells       Date:  2021-03-02       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.